The analysis of NEFH methylation in tumor samples of patients undergoing targeted therapy for treatment of mRCC revealed a bimodal distribution of methylation values identifying low-and high-methylated tissue groups making a statistical calculation of a cutoff value for dichotomization redundant (Fig. 3C). The gene discussed is NEFH; the disease is neoplasm.